Predictors of decline in walking ability in community-dwelling Alzheimer's disease patients: Results from the 4-years prospective REAL.FR study

Archive ouverte

Rolland, Yves | Cantet, Christelle | Barreto, Philipe De, Souto | Cesari, Matteo | van Kan, Gabor, Abellan | Vellas, Bruno

Edité par CCSD ; BioMed Central -

International audience. Introduction
The aim of this study was to explore the predictors of decline in walking ability in patients with Alzheimer's disease (AD).
Methods
The prospective REseau surla maladie ALzheimer FRançais (REAL.FR) study enrolled six hundred eighty four community-dwelling AD subjects (71.20% women; mean age 77.84 Standard Deviation, SD, 6.82 years, Mini-Mental State Examination 20.02, SD 4.23). Decline in walking ability was defined as the first loss of 0.5 points or more in the walking ability item of the Activities of Daily Living scale (ADL), where higher score means greater independence, during the four-years of follow-up. Demographic characteristics, co-morbidities, and level of education were reported at baseline. Disability, caregiver burden, cognitive and nutritional status, body mass index, balance, behavioral and psychological symptoms of dementia, medication, hospitalization, institutionalization and death were reported every six months during the four years. Cox survival analyses were performed to assess the independent factors associated with decline in walking ability.
Results
The mean incident decline in walking ability was 12.76% per year (95% Confidence Interval (CI) 10.86 to 14.66). After adjustment for confounders, the risk of decline in walking ability was independently associated with older age (Relative Risk, RR = 1.05 (95% CI 1.02 to 1.08)), time from diagnosis of dementia (RR = 1.16 (1.01 to 1.33)), painful osteoarthritis (RR = 1.84 (1.19 to 2.85)), hospitalization for fracture of the lower limb (RR = 6.35 (3.02 to 13.37)), higher baseline ADL score (RR = 0.49 (0.43 to 0.56)), and the use of acetylcholinesterase inhibitors (RR = 0.52 (0.28 to 0.96)).
Conclusions
The risk of decline in walking ability is predicted by older age, increased dementia severity, poor functional score, and orthopedic factors and seems to be prevented by the use of acetylcholinesterase inhibitors medication.

Suggestions

Du même auteur

The associations between biological markers of aging and appetite loss across adulthood: retrospective case–control data from the INSPIRE-T study

Archive ouverte | Turesson, Annelie | CCSD

International audience. Appetite loss is a common clinical condition in older adulthood, but how this condition associates with biological aging remains unknown. The present study aims to examine the associations of...

Plasma MCP-1 and changes on cognitive function in community-dwelling older adults

Archive ouverte | Sánchez-Sánchez, Juan Luis | CCSD

International audience. Background: Monocyte Chemoattractant Protein-1 (MCP-1), a glial-derived chemokine, mediates neuroinflammation and may regulate memory outcomes among older adults. We aimed to explore the asso...

Low circulating adropin concentrations predict increased risk of cognitive decline in community-dwelling older adults

Archive ouverte | Aggarwal, Geetika | CCSD

International audience. Abstract The secreted peptide adropin is highly expressed in human brain tissues and correlates with RNA and proteomic risk indicators for dementia. Here we report that plasma adropin concent...

Chargement des enrichissements...